SPRT near to strong support level

SPRT near to strong weekly support level. possibly buy. wait for confirmation. I cant believe the Food and Drug Administration rejected the latest Duchenne muscular dystrophy drug, dubbed golodirsen. This could get ugly. Watching for a bounce and keeping an eye on the overall market as well. also watching this one.